tiprankstipranks
Beauty Farm Medical & Health Industry, Inc. (HK:2373)
:2373
Hong Kong Market
2373
Beauty Farm Medical & Health Industry, Inc.
RESEARCH TOOLSreports

Beauty Farm Medical & Health Industry, Inc. (2373) Ratios

2 Followers

Beauty Farm Medical & Health Industry, Inc. Ratios

HK:2373's free cash flow for Q2 2025 was ¥0.49. For the 2025 fiscal year, HK:2373's free cash flow was decreased by ¥ and operating cash flow was ¥0.15. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
 0.98 0.80 0.94 0.65 0.71
Quick Ratio
 0.95 0.74 0.83 0.56 0.65
Cash Ratio
 0.39 0.17 0.11 0.09 0.08
Solvency Ratio
 0.15 0.10 0.22 0.17 0.21
Operating Cash Flow Ratio
 0.34 0.29 0.30 0.20 0.36
Short-Term Operating Cash Flow Coverage
 3.29 40.16 0.00 0.00 -0.42
Net Current Asset Value
¥ -1.12B¥ -1.12B¥ -531.87M¥ -1.04B¥ -905.30M
Leverage Ratios
Debt-to-Assets Ratio
 0.26 0.17 0.17 0.21 0.21
Debt-to-Equity Ratio
 1.27 0.77 0.70 2.78 2.00
Debt-to-Capital Ratio
 0.56 0.44 0.41 0.74 0.67
Long-Term Debt-to-Capital Ratio
 0.39 0.12 0.00 0.00 0.00
Financial Leverage Ratio
 4.94 4.53 4.12 13.22 9.63
Debt Service Coverage Ratio
 1.84 7.64 23.65 17.50 -0.32
Interest Coverage Ratio
 22.88 11.68 11.74 6.15 11.48
Debt to Market Cap
 0.22 0.04 0.00 0.00 -0.29
Interest Debt Per Share
 5.57 3.29 2.56 2.39 2.34
Net Debt to EBITDA
 0.22 0.64 0.53 0.80 0.65
Profitability Margins
Gross Profit Margin
48.38%46.26%45.55%43.89%46.82%
EBIT Margin
14.58%12.06%14.60%9.49%15.69%
EBITDA Margin
23.42%16.62%30.06%27.66%31.14%
Operating Profit Margin
14.97%12.51%13.58%9.30%15.61%
Pretax Profit Margin
15.00%12.36%13.44%7.98%14.33%
Net Profit Margin
10.58%8.88%10.05%6.30%10.86%
Continuous Operations Profit Margin
11.34%9.82%10.73%6.76%11.70%
Net Income Per EBT
70.56%71.87%74.81%79.03%75.84%
EBT Per EBIT
100.24%98.78%98.96%85.79%91.75%
Return on Assets (ROA)
6.24%5.34%6.53%4.13%7.81%
Return on Equity (ROE)
33.08%24.18%26.89%54.63%75.18%
Return on Capital Employed (ROCE)
20.83%20.93%23.30%25.94%44.59%
Return on Invested Capital (ROIC)
13.82%14.38%16.38%17.48%-28.11%
Return on Tangible Assets
7.87%6.98%7.18%4.65%8.82%
Earnings Yield
7.80%5.92%9.36%1.71%3.47%
Efficiency Ratios
Receivables Turnover
 34.90 34.40 32.78 28.39 42.23
Payables Turnover
 42.20 46.25 54.52 116.78 61.35
Inventory Turnover
 14.26 9.10 5.05 4.95 9.74
Fixed Asset Turnover
 3.67 2.67 2.41 2.07 2.50
Asset Turnover
 0.59 0.60 0.65 0.66 0.72
Working Capital Turnover Ratio
 -12.17 -7.69 -5.52 -2.71 -3.11
Cash Conversion Cycle
 27.41 42.81 76.75 83.41 40.18
Days of Sales Outstanding
 10.46 10.61 11.14 12.86 8.64
Days of Inventory Outstanding
 25.60 40.09 72.31 73.68 37.48
Days of Payables Outstanding
 8.65 7.89 6.69 3.13 5.95
Operating Cycle
 36.06 50.70 83.45 86.54 46.13
Cash Flow Ratios
Operating Cash Flow Per Share
 4.17 3.45 2.73 1.66 2.91
Free Cash Flow Per Share
 4.40 2.96 2.03 1.05 2.33
CapEx Per Share
 0.22 0.49 0.69 0.61 0.58
Free Cash Flow to Operating Cash Flow
 1.05 0.86 0.75 0.63 0.80
Dividend Paid and CapEx Coverage Ratio
 6.03 3.51 2.54 1.11 3.13
Capital Expenditure Coverage Ratio
 18.84 6.98 3.93 2.71 5.03
Operating Cash Flow Coverage Ratio
 0.76 1.09 1.11 0.73 1.30
Operating Cash Flow to Sales Ratio
 0.33 0.31 0.29 0.23 0.38
Free Cash Flow Yield
24.17%17.69%20.24%4.00%9.64%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 12.83 16.89 10.68 58.55 28.78
Price-to-Sales (P/S) Ratio
 1.44 1.50 1.07 3.69 3.13
Price-to-Book (P/B) Ratio
 3.95 4.08 2.87 31.98 21.63
Price-to-Free Cash Flow (P/FCF) Ratio
 4.14 5.65 4.94 25.03 10.37
Price-to-Operating Cash Flow Ratio
 4.10 4.84 3.68 15.80 8.31
Price-to-Earnings Growth (PEG) Ratio
 0.83 3.17 0.10 -1.26 0.98
Price-to-Fair Value
 3.95 4.08 2.87 31.98 21.63
Enterprise Value Multiple
 6.38 9.67 4.10 14.14 10.69
Enterprise Value
 4.44B 4.13B 2.64B 6.40B 5.93B
EV to EBITDA
 6.38 9.67 4.10 14.14 10.69
EV to Sales
 1.49 1.61 1.23 3.91 3.33
EV to Free Cash Flow
 4.29 6.06 5.67 26.53 11.04
EV to Operating Cash Flow
 4.51 5.19 4.22 16.75 8.85
Tangible Book Value Per Share
 0.08 -0.12 2.34 -0.33 -0.10
Shareholders’ Equity Per Share
 4.34 4.09 3.50 0.82 1.12
Tax and Other Ratios
Effective Tax Rate
 0.24 0.21 0.20 0.15 0.18
Revenue Per Share
 12.62 11.15 9.35 7.09 7.72
Net Income Per Share
 1.34 0.99 0.94 0.45 0.84
Tax Burden
 0.71 0.72 0.75 0.79 0.76
Interest Burden
 1.03 1.02 0.92 0.84 0.91
Research & Development to Revenue
 0.01 0.01 0.02 0.02 0.01
SG&A to Revenue
 0.32 0.33 0.01 0.04 0.02
Stock-Based Compensation to Revenue
 <0.01 >-0.01 <0.01 <0.01 <0.01
Income Quality
 3.66 2.51 2.17 2.93 2.63
Currency in CNY